Institute for Cancer Genetics, Columbia University, New York, NY;
Blood. 2013 Oct 3;122(14):2425-32. doi: 10.1182/blood-2013-05-500850. Epub 2013 Aug 1.
The SH2B adaptor protein 3 (SH2B3) gene encodes a negative regulator of cytokine signaling with a critical role in the homeostasis of hematopoietic stem cells and lymphoid progenitors. Here, we report the identification of germline homozygous SH2B3 mutations in 2 siblings affected with developmental delay and autoimmunity, one in whom B-precursor acute lymphoblastic leukemia (ALL) developed. Mechanistically, loss of SH2B3 increases Janus kinase-signal transducer and activator of transcription signaling, promotes lymphoid cell proliferation, and accelerates leukemia development in a mouse model of NOTCH1-induced ALL. Moreover, extended mutation analysis showed homozygous somatic mutations in SH2B3 in 2 of 167 ALLs analyzed. Overall, these results demonstrate a Knudson tumor suppressor role for SH2B3 in the pathogenesis of ALL and highlight a possible link between genetic predisposition factors in the pathogenesis of autoimmunity and leukemogenesis.
SH2B 衔接蛋白 3(SH2B3)基因编码细胞因子信号的负调节剂,在造血干细胞和淋巴祖细胞的动态平衡中具有关键作用。在这里,我们报道了 2 名受发育迟缓及自身免疫影响的同胞中同系生殖 SH2B3 突变的鉴定,其中 1 名发展为前 B 细胞急性淋巴细胞白血病(ALL)。从机制上讲,SH2B3 的缺失增加了 Janus 激酶-信号转导和转录激活因子信号,促进了淋巴样细胞增殖,并加速了 NOTCH1 诱导的 ALL 小鼠模型中的白血病发展。此外,扩展的突变分析显示,在分析的 167 例 ALL 中,有 2 例存在 SH2B3 的纯合体细胞突变。总体而言,这些结果表明 SH2B3 在 ALL 的发病机制中具有 Knudson 肿瘤抑制因子的作用,并强调了遗传易感性因素在自身免疫和白血病发生中的可能联系。